Alleghany General Hospital is a clinical research site located in Pittsburgh, Pennsylvania, United States 15212.
Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.
Alleghany General Hospital has participated in 9 clinical trials with 5 currently active.
Therapeutic areas: Grade 2 and 3 Late Xerostomia Caused by Radiotherapy for Cancers of the Upper Aerodigestive Tract, Excluding the Parotid Glands, Amyotrophic Lateral Sclerosis (ALS), Idiopathic Pulmonary Fibrosis.
Sponsors: MeiraGTx, LLC, Tanabe Pharma America, Inc., Gilead Sciences.
Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Alleghany General Hospital has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Alleghany General Hospital has 9 clinical trials on record, with 5 currently active. Their work covers Grade 2 and 3 Late Xerostomia Caused by Radiotherapy for Cancers of the Upper Aerodigestive Tract, Excluding the Parotid Glands, Amyotrophic Lateral Sclerosis (ALS), Idiopathic Pulmonary Fibrosis.
Yes — Alleghany General Hospital holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.